Biotech ETFs invest in stocks of companies in the biotechnology industry, many of which are involved in the use of biological processes such as recombinant DNA technology, molecular biology, genetic engineering, and genomics.
Biotech ETFs invest in stocks of companies in the biotechnology industry, many of which are involved in the use of biological processes such as recombinant DNA technology, molecular biology, genetic engineering, and genomics.
Click on the tabs below to see more information on Biotechnology ETFs, including historical performance, dividends, holdings, expense ratios, technical indicators, analysts reports and more. Click on an ETF ticker or name to go to its detail page, for in-depth news, financial data and graphs. By default the list is ordered by descending total market capitalization. Note that ETFs are usually tagged by ETF Database analysts as more than one type; for example, an inverse gold ETF may be tagged as “inverse” and as “gold” and as “commodity”.
Note that the table below may include leveraged and inverse ETFs. Include Leveraged and Inverse ETFs
As of 09/06/2024
This is a list of all Biotechnology ETFs traded in the USA which are currently tagged by ETF Database. Please note that the list may not contain newly issued ETFs. If you’re looking for a more simplified way to browse and compare ETFs, you may want to visit our ETF Database Categories, which categorize every ETF in a single “best fit” category.
* Assets and Average Volume as of 2024-09-06 1:00 EDT
This page includes historical return information for all Biotechnology ETFs listed on U.S. exchanges that are currently tracked by ETF Database.
The table below includes fund flow data for all U.S. listed Biotechnology ETFs. Total fund flow is the capital inflow into an ETF minus the capital outflow from the ETF for a particular time period.
Fund Flows in millions of U.S. Dollars.
The following table includes expense data and other descriptive information for all Biotechnology ETFs listed on U.S. exchanges that are currently tracked by ETF Database. In addition to expense ratio and issuer information, this table displays platforms that offer commission-free trading for certain ETFs.
Clicking on any of the links in the table below will provide additional descriptive and quantitative information on Biotechnology ETFs.
The following table includes ESG Scores and other descriptive information for all Biotechnology ETFs listed on U.S. exchanges that are currently tracked by ETF Database. Easily browse and evaluate ETFs by visiting our ESG Investing themes section and find ETFs that map to various environmental, social, governance and morality themes.
This page includes historical dividend information for all Biotechnology ETFs listed on U.S. exchanges that are currently tracked by ETF Database. Note that certain ETPs may not make dividend payments, and as such some of the information below may not be meaningful.
The table below includes basic holdings data for all U.S. listed Biotechnology ETFs that are currently tagged by ETF Database. The table below includes the number of holdings for each ETF and the percentage of assets that the top ten assets make up, if applicable. For more detailed holdings information for any ETF, click on the link in the right column.
The following table includes certain tax information for all Biotechnology ETFs listed on U.S. exchanges that are currently tracked by ETF Database, including applicable short-term and long-term capital gains rates and the tax form on which gains or losses in each ETF will be reported.
This page contains certain technical information for all Biotechnology ETFs that are listed on U.S. exchanges and tracked by ETF Database. Note that the table below only includes limited technical indicators; click on the “View” link in the far right column for each ETF to see an expanded display of the product’s technicals.
This page provides links to various analysis for all Biotechnology ETFs that are listed on U.S. exchanges and tracked by ETF Database. The links in the table below will guide you to various analytical resources for the relevant ETF, including an X-ray of holdings, official fund fact sheet, or objective analyst report.
This page provides ETF Database Ratings for all Biotechnology ETFs that are listed on U.S. exchanges and tracked by ETF Database. The ETF Database Ratings are transparent, quant-based evaluations of ETFs relative to other products in the same ETF Database Category. As such, it should be noted that this page may include ETFs from multiple ETF Database Categories.
Symbol Symbol | ETF Name ETF Name | Asset Class Asset Class | Sector Sector | Total Assets ($MM) Total Assets ($MM) | YTD YTD | Avg Volume Avg Volume | Previous Closing Price Previous Closing Price | 1-Day Change 1-Day Change | 1 Week 1 Week | 1 Month 1 Month | 1 Year 1 Year | 3 Year 3 Year | 5 Year 5 Year | YTD FF YTD FF | 1 Week FF 1 Week FF | 4 Week FF 4 Week FF | 1 Year FF 1 Year FF | 3 Year FF 3 Year FF | 5 Year FF 5 Year FF | ETF Database Category ETF Database Category | Inception Inception | ER ER | Commission Free Commission Free | Annual Dividend Rate Annual Dividend Rate | Dividend Date Dividend Date | Dividend Dividend | Annual Dividend Yield % Annual Dividend Yield % | P/E Ratio P/E Ratio | Beta Beta | # of Holdings # of Holdings | % In Top 10 % In Top 10 | Complete Complete | ST Cap Gain Rate ST Cap Gain Rate | LT Cap Gain Rate LT Cap Gain Rate | Tax Form Tax Form | Lower Bollinger Lower Bollinger | Upper Bollinger Upper Bollinger | Support 1 Support 1 | Resistance 1 Resistance 1 | RSI RSI | Advanced Advanced | Fact Sheet Fact Sheet | ETF Holdings ETF Holdings | Chart Chart | ETF Home Page ETF Home Page | Head-To-Head Head-To-Head | Overall Rating Overall Rating | Liquidity Rating Liquidity Rating | Expenses Rating Expenses Rating | Returns Rating Returns Rating | Volatility Rating Volatility Rating | Dividend Rating Dividend Rating | Concentration Rating Concentration Rating |
ESG Score
ESG Score
|
ESG Score Peer Percentile (%)
ESG Score Peer Percentile (%)
|
ESG Score Global Percentile (%)
ESG Score Global Percentile (%)
|
Carbon Intensity (Tons of CO2e / $M Sales)
Carbon Intensity (Tons of CO2e / $M Sales)
|
SRI Exclusion Criteria (%)
SRI Exclusion Criteria (%)
|
Sustainable Impact Solutions (%)
Sustainable Impact Solutions (%)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBI | SPDR S&P Biotech ETF | Equity | Healthcare | $7,816.84 | 9.98% | 7,752,052 | $98.08 | -0.45% | -2.80% | 1.67% | 22.94% | -9.88% | 4.46% | Health & Biotech Equities | 2006-01-31 | 0.35% | N/A | $0.13 | 2024-06-24 | $0.12 | 0.13% | 17.88 | 0.97 | 138 | 29.66% | View | 40% | 20% | 1099 | $94.34 | $103.59 | $97.38 | $98.83 | 50.08 | View | View | View | View | View | View | A+ | A | 5.46 | 22.31% | 28.17% | 37.28 | 0.00% | 25.91% | |||||||||||
IBB | iShares Biotechnology ETF | Equity | Healthcare | $7,714.31 | 6.68% | 1,228,423 | $144.79 | -0.49% | -2.35% | 0.43% | 14.08% | -6.01% | 7.70% | Health & Biotech Equities | 2001-02-05 | 0.45% | N/A | $0.40 | 2024-03-21 | $0.13 | 0.28% | 15.68 | 0.84 | 211 | 51.23% | View | 40% | 20% | 1099 | $140.87 | $150.55 | $143.68 | $145.83 | 50.52 | View | View | View | View | View | View | A | B | 6.81 | 68.62% | 61.28% | 22.2 | 0.00% | 28.44% | |||||||||||
ARKG | ARK Genomic Revolution ETF | Equity | Healthcare | $1,292.67 | -23.90% | 2,412,273 | $24.97 | 0.40% | -6.06% | 1.42% | -21.97% | -33.98% | -2.41% | Health & Biotech Equities | 2014-10-31 | 0.75% | N/A | $0.00 | 2021-12-29 | $0.38 | 0.00% | 0.00 | 1.50 | 38 | 52.82% | View | 40% | 20% | 1099 | $23.94 | $27.63 | $24.68 | $25.27 | 46.63 | View | View | View | View | View | View | A | C+ | 5.53 | 23.82% | 29.09% | 29.64 | 0.00% | 14.72% | |||||||||||
FBT | First Trust NYSE Arca Biotechnology Index Fund | Equity | Healthcare | $1,153.50 | 5.13% | 24,402 | $166.17 | -0.61% | -2.90% | 0.16% | 8.90% | -1.32% | 6.12% | Health & Biotech Equities | 2006-06-19 | 0.56% | N/A | $0.00 | 2021-12-30 | $2.21 | 0.00% | 17.55 | 0.79 | 31 | 37.73% | View | 40% | 20% | 1099 | $163.84 | $173.24 | $165.14 | $167.46 | 51.48 | View | View | View | View | View | View | B+ | B- | 6.14 | 37.24% | 39.45% | 28.63 | 0.00% | 39.84% | |||||||||||
BBH | VanEck Biotech ETF | Equity | Healthcare | $453.46 | 7.10% | 6,223 | $177.05 | -0.61% | -2.63% | -0.76% | 10.57% | -6.64% | 8.19% | Health & Biotech Equities | 2011-12-20 | 0.35% | N/A | $0.71 | 2023-12-18 | $0.71 | 0.40% | 15.63 | 0.85 | 27 | 69.52% | View | 40% | 20% | 1099 | $174.72 | $184.32 | $176.15 | $177.66 | 48.90 | View | View | View | View | View | View | B | A- | 7.34 | 94.71% | 82.65% | 15.2 | 0.00% | 38.36% | |||||||||||
PBE | Invesco Biotechnology & Genome ETF | Equity | Healthcare | $265.30 | 5.26% | 9,464 | $69.27 | -0.93% | -3.56% | 1.17% | 14.34% | -4.28% | 7.09% | Health & Biotech Equities | 2005-06-23 | 0.58% | N/A | $0.03 | 2024-06-24 | $0.01 | 0.05% | 118.60 | 0.87 | 32 | 48.08% | View | 40% | 20% | 1099 | $67.57 | $72.87 | $68.88 | $69.53 | 49.89 | View | View | View | View | View | View | B | B- | 5.51 | 23.25% | 28.82% | 31.03 | 0.00% | 40.61% | |||||||||||
IDNA | iShares Genomics Immunology and Healthcare ETF | Equity | Healthcare | $138.68 | 6.13% | 31,950 | $24.31 | 0.12% | -2.60% | 2.30% | 9.73% | -23.24% | -0.24% | Health & Biotech Equities | 2019-06-11 | 0.47% | N/A | $0.28 | 2024-06-11 | $0.11 | 1.15% | 11.11 | 0.90 | 48 | 46.25% | View | 40% | 20% | 1099 | $23.55 | $25.45 | N/A | N/A | 49.16 | View | View | View | View | View | View | B+ | B | 5.65 | 24.76% | 30.62% | 32.68 | 0.00% | 25.25% | |||||||||||
SBIO | ALPS Medical Breakthroughs ETF | Equity | Healthcare | $111.81 | 10.53% | 6,805 | $36.41 | -0.74% | -1.68% | 2.45% | 22.09% | -8.30% | 1.46% | Health & Biotech Equities | 2014-12-31 | 0.50% | N/A | $0.07 | 2023-12-21 | $0.07 | 0.19% | 0.00 | 0.92 | 101 | 28.43% | View | 40% | 20% | 1099 | $34.33 | $38.24 | N/A | N/A | 51.34 | View | View | View | View | View | View | B | B | 5.27 | 20.23% | 25.66% | 51.73 | 0.00% | 8.05% | |||||||||||
HRTS | Tema GLP-1 Obesity & Cardiometabolic ETF | Equity | Healthcare | $86.20 | 11.63% | 26,508 | $34.17 | -1.39% | -2.93% | 1.12% | N/A | N/A | N/A | Health & Biotech Equities | 2023-11-21 | 0.75% | N/A | $0.00 | N/A | N/A | 0.00% | N/A | N/A | 46 | 44.75% | View | 40% | 20% | 1099 | $32.72 | $35.94 | $34.04 | $34.39 | 49.62 | View | View | View | View | View | View | N/A | B- | 6.43 | 45.18% | 45.99% | 24.34 | 0.00% | 30.01% | |||||||||||
GNOM | Global X Genomics & Biotechnology ETF | Equity | Healthcare | $81.66 | -5.00% | 57,864 | $10.98 | 0.09% | -4.44% | -0.90% | -1.70% | -23.80% | -3.89% | Health & Biotech Equities | 2019-04-05 | 0.50% | N/A | $0.00 | 2021-12-30 | $0.01 | 0.00% | -17.62 | 1.03 | 43 | 45.22% | View | 40% | 20% | 1099 | $10.88 | $11.72 | $10.90 | $11.05 | 46.14 | View | View | View | View | View | View | A- | B | 5.83 | 29.49% | 33.33% | 33.54 | 0.00% | 18.67% | |||||||||||
CANC | Tema Oncology ETF | Equity | Healthcare | $50.22 | 8.42% | 16,786 | $28.62 | -2.09% | -3.73% | 1.17% | 16.67% | N/A | N/A | Health & Biotech Equities | 2023-08-15 | 0.75% | N/A | $0.15 | 2023-12-13 | $0.15 | 0.52% | N/A | N/A | 49 | 41.59% | View | 40% | 20% | 1099 | $27.62 | $30.40 | $28.46 | $28.95 | 48.17 | View | View | View | View | View | View | B | B- | 6.42 | 44.99% | 45.86% | 30.67 | 0.00% | 29.02% | |||||||||||
BBP | Virtus LifeSci Biotech Products ETF | Equity | Healthcare | $22.06 | 7.34% | 1,958 | $62.36 | -1.03% | -2.42% | 2.99% | 17.54% | 5.59% | 11.40% | Health & Biotech Equities | 2014-12-17 | 0.79% | N/A | $0.00 | 2017-12-20 | $0.07 | 0.00% | 0.00 | 0.73 | 63 | 21.44% | View | 40% | 20% | 1099 | $59.50 | $65.54 | N/A | N/A | 51.48 | View | View | View | View | View | View | C | C | 4.3 | 7.56% | 9.44% | 45.2 | 0.00% | 33.67% | |||||||||||
CNCR | Range Cancer Therapeutics ETF | Equity | Healthcare | $12.74 | 7.39% | 7,137 | $14.47 | -0.07% | -3.30% | 1.66% | 21.05% | -20.76% | -3.86% | Health & Biotech Equities | 2015-10-13 | 0.79% | N/A | $0.00 | 2021-12-29 | $1.85 | 0.00% | 0.00 | 0.90 | 77 | 24.93% | View | 40% | 20% | 1099 | $13.41 | $15.52 | $14.44 | $14.48 | 48.75 | View | View | View | View | View | View | C+ | C | 5.35 | 21.17% | 26.70% | 47.07 | 0.00% | 3.32% | |||||||||||
MNTL | Tema Neuroscience and Mental Health ETF | Equity | Healthcare | $11.84 | N/A | 536 | $26.67 | -1.11% | -2.69% | 0.96% | N/A | N/A | N/A | Health & Biotech Equities | 2024-01-22 | 0.75% | N/A | $0.00 | N/A | N/A | 0.00% | N/A | N/A | 48 | 46.60% | View | 40% | 20% | 1099 | $25.95 | $28.06 | $26.67 | $26.67 | 49.13 | View | View | View | View | View | View | N/A | B- | 6.45 | 46.12% | 46.51% | 31.49 | 0.00% | 38.28% | |||||||||||
BBC | Virtus LifeSci Biotech Clinical Trials ETF | Equity | Healthcare | $10.87 | 11.22% | 2,670 | $27.20 | 0.07% | -2.05% | 0.36% | 27.38% | -17.26% | 0.95% | Health & Biotech Equities | 2014-12-16 | 0.79% | N/A | $0.08 | 2023-12-20 | $0.08 | 0.30% | 0.00 | 1.08 | 121 | 13.42% | View | 40% | 20% | 1099 | $25.48 | $28.66 | $27.18 | $27.23 | 49.51 | View | View | View | View | View | View | C+ | C | 5.79 | 28.17% | 32.73% | 49.92 | 0.00% | 0.00% | |||||||||||
HELX | Franklin Genomic Advancements ETF | Equity | Healthcare | $9.69 | 5.49% | 2,352 | $32.14 | -0.56% | -3.44% | -1.96% | 6.50% | -17.81% | N/A | Health & Biotech Equities | 2020-02-25 | 0.50% | N/A | $0.00 | 2021-12-30 | $0.00 | 0.00% | 18.88 | 1.02 | 57 | 47.08% | View | 40% | 20% | 1099 | $31.84 | $33.98 | $32.07 | $32.20 | 44.49 | View | View | View | View | View | View | C | B | 6.14 | 37.43% | 39.53% | 25.41 | 2.06% | 23.03% | |||||||||||
PSIL | AdvisorShares Psychedelics ETF | Equity | Healthcare | $4.70 | -41.61% | 56,422 | $0.81 | -2.41% | -7.62% | -20.43% | -54.39% | N/A | N/A | Health & Biotech Equities | 2021-09-15 | 0.99% | N/A | $0.00 | 2023-09-25 | $0.00 | 0.37% | 0.00 | 0.93 | 25 | 69.38% | View | 40% | 20% | 1099 | $0.82 | $0.96 | $0.80 | $0.83 | 31.40 | View | View | View | View | View | View | A- | C | 0.0 | N/A | N/A | N/A | N/A | N/A | |||||||||||
WDNA | WisdomTree BioRevolution Fund | Equity | Healthcare | $2.46 | N/A | N/A | N/A | 0.00% | N/A | N/A | N/A | N/A | N/A | Health & Biotech Equities | 2021-06-03 | 0.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 92 | 24.04% | View | 40% | 20% | 1099 | N/A | N/A | N/A | N/A | View | View | View | View | View | View | N/A | B+ | 5.97 | 32.70% | 36.12% | 62.79 | 2.50% | 18.91% | ||||||||||||
Click Here to Join to ETF Database Pro for 14 Days Free, Export This Data & So Much More |
Industry power rankings are rankings between Biotechnology and all other industry U.S.-listed ETFs on certain investment-related metrics, including 3-month fund flows, 3-month return, AUM, average ETF expenses and average dividend yields. The metric calculations are based on U.S.-listed ETFs that are classified by ETF Database as being mostly exposed to a specific industry. If an ETF changes its industry classification, it will also be reflected in the investment metric calculations. The calculations exclude inverse ETFs.
Biotechnology and all other industries are ranked based on their aggregate 3-month fund flows for all U.S.-listed ETFs that are classified by ETF Database as being mostly exposed to those respective industries. 3-month fund flows is a metric that can be used to gauge the perceived popularity amongst investors of Biotechnology relative to other industries. If an ETF’s industry classification changes, it will affect the fund flow calculations. The calculations exclude inverse ETFs. All values are in U.S. dollars.
Biotechnology and all other industries are ranked based on their AUM-weighted average 3-month return for all the U.S.-listed ETFs that are classified by ETF Database as being mostly exposed to those respective industries. In addition to price performance, the 3-month return assumes the reinvestment of all dividends during the last 3 months. If an ETF’s industry classification changes, it will affect the 3-month return calculations. The calculations exclude inverse ETFs.
Biotechnology and all other industries are ranked based on their aggregate assets under management (AUM) for all the U.S.-listed ETFs that are classified by ETF Database as being mostly exposed to those respective industries. If an ETF’s industry classification changes, it will affect the aggregate AUM calculations. The calculations exclude inverse ETFs. All values are in U.S. dollars.
Biotechnology and all other industries are ranked based on their AUM-weighted average expense ratios for all the U.S.-listed ETFs that are classified by ETF Database as being mostly exposed to those respective industries. The lower the average expense ratio for all U.S.-listed ETFs in an industry, the higher the rank. If an ETF’s industry classification changes, it will affect the expense ratio calculations. The calculations exclude inverse ETFs.
Biotechnology and all other industries are ranked based on their AUM-weighted average dividend yield for all the U.S.-listed ETFs that are classified by ETF Database as being mostly exposed to those respective industries. If an ETF’s industry classification changes, it will affect the dividend yield calculations. The calculations exclude inverse ETFs.
Industry Industry | Fund Flow Rank Fund Flow Rank |
+/- |
3-Month Fund Flow ($MM) 3-Month Fund Flow ($MM) | Return Rank Return Rank |
+/- |
Avg. 3-Month Return (%) Avg. 3-Month Return (%) | AUM Rank AUM Rank |
+/- |
Assets Under Management ($MM) Assets Under Management ($MM) | Expense Rank Expense Rank |
+/- |
Avg. Expense Ratio (%) Avg. Expense Ratio (%) | Dividend Rank Dividend Rank |
+/- |
Avg. Dividend Yield (%) Avg. Dividend Yield (%) | # of ETFs # of ETFs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Semiconductors | 1 | 1 | 77 | 7 | 5 | - | 41 | 1 | 57 | 1 | 17 | |||||
Broad Technology | 2 | 1 | 52 | 9 | 1 | - | 12 | - | 65 | 2 | 92 | |||||
Broad Financials | 3 | - | 13 | 6 | 4 | - | 8 | - | 38 | 1 | 22 | |||||
Broad Real Estate | 4 | 1 | 6 | - | 2 | - | 7 | - | 14 | 1 | 39 | |||||
Broad Utilities | 5 | 1 | 12 | 17 | 10 | - | 2 | - | 21 | 1 | 15 | |||||
Broad Consumer Staples | 6 | - | 20 | 8 | 8 | - | 6 | - | 26 | 1 | 14 | |||||
Banks | 7 | - | 7 | - | 30 | - | 14 | - | 23 | - | 4 | |||||
Regional Banks | 8 | - | 2 | 1 | 26 | - | 34 | 2 | 22 | - | 4 | |||||
Automotive | 9 | - | 1 | 4 | 40 | 1 | 78 | - | 7 | 2 | 11 | |||||
Energy Infrastructure | 10 | - | 11 | 2 | 36 | 1 | 30 | 1 | 9 | - | 3 | |||||
Residential Real Estate | 11 | 10 | 5 | 1 | 50 | 4 | 38 | - | 27 | - | 1 | |||||
Aerospace & Defense | 12 | 4 | 24 | 3 | 16 | - | 32 | 2 | 63 | - | 7 | |||||
Infrastructure | 13 | 10 | 32 | 13 | 14 | - | 27 | - | 34 | - | 11 | |||||
Homebuilders | 14 | 3 | 9 | - | 23 | - | 25 | 1 | 70 | - | 6 | |||||
Capital Markets | 15 | 3 | 15 | 8 | 57 | - | 13 | - | 35 | - | 1 | |||||
Cryptocurrency | 16 | 2 | 80 | 1 | 55 | 2 | 77 | - | 68 | 1 | 8 | |||||
Broad Industrials | 17 | 5 | 29 | 3 | 7 | - | 9 | 1 | 51 | - | 19 | |||||
Electric Energy Infrastructure | 18 | 5 | 50 | 1 | 41 | 1 | 46 | 4 | 54 | - | 2 | |||||
Internet Architecture | 19 | 4 | 21 | 3 | 21 | - | 49 | - | 72 | - | 3 | |||||
Broker-Dealers | 20 | 2 | 17 | 3 | 44 | 2 | 22 | - | 43 | 2 | 1 | |||||
Insurance | 21 | 2 | 10 | 4 | 37 | 1 | 15 | - | 49 | 2 | 3 | |||||
Business Development Company | 22 | 5 | 56 | 4 | 43 | - | 80 | - | 2 | - | 4 | |||||
Software | 23 | 1 | 26 | 10 | 20 | - | 33 | - | 78 | - | 7 | |||||
MLP | 24 | 31 | 25 | - | 15 | - | 76 | - | 6 | 1 | 14 | |||||
Manufacturing | 25 | - | 43 | 3 | 71 | - | 73 | - | 76 | - | 2 | |||||
Consumer Services | 26 | 6 | 31 | 6 | 48 | 1 | 18 | 1 | 67 | 2 | 1 | |||||
Mortgage REITs | 27 | 6 | 16 | 1 | 51 | 1 | 31 | - | 3 | - | 7 | |||||
Water | 28 | 1 | 36 | - | 24 | - | 47 | 1 | 62 | - | 7 | |||||
Consumer Goods | 29 | 6 | 19 | 8 | 42 | 2 | 21 | 3 | 11 | - | 1 | |||||
Community Banks | 30 | 2 | 3 | 1 | 70 | - | 57 | - | 24 | - | 1 | |||||
Nuclear Energy | 31 | 5 | 74 | 1 | 66 | - | 59 | - | 10 | - | 1 | |||||
Uranium | 32 | 5 | 79 | 1 | 29 | 1 | 69 | - | 8 | - | 3 | |||||
Internet Infrastructure | 33 | 3 | 51 | 20 | 60 | - | 40 | - | 66 | - | 4 | |||||
Private Equity | 34 | 2 | 35 | 6 | 62 | - | 79 | - | 4 | - | 2 | |||||
Nanotechnology | 35 | 2 | 70 | 8 | 78 | - | 50 | 1 | 75 | - | 1 | |||||
Aluminum | 36 | 2 | 68 | 6 | 80 | - | 64 | 1 | 59 | 1 | 1 | |||||
Networking | 37 | 2 | 38 | 8 | 75 | - | 20 | 1 | 48 | 2 | 1 | |||||
Shipping | 38 | 2 | 72 | - | 74 | - | 68 | - | 5 | 1 | 3 | |||||
Environmental Services | 39 | 5 | 30 | 8 | 73 | - | 44 | 2 | 60 | 1 | 1 | |||||
YieldCos | 40 | 1 | 47 | 8 | 76 | - | 63 | 1 | 42 | - | 1 | |||||
Hard Assets Producers | 41 | 1 | 57 | - | 69 | - | 28 | - | 17 | 1 | 1 | |||||
Rare Earth/Strategic Metals | 42 | 2 | 78 | - | 79 | - | 75 | - | 18 | - | 1 | |||||
Timber | 43 | 2 | 49 | 4 | 63 | - | 35 | - | 36 | - | 2 | |||||
Industrial/Office Real Estate | 44 | 3 | 8 | - | 65 | - | 54 | 10 | 12 | - | 1 | |||||
Global Warming | 45 | 6 | 48 | 1 | 77 | - | 39 | - | 56 | - | 1 | |||||
Steel | 46 | 6 | 69 | - | 72 | - | 45 | 2 | 15 | 2 | 1 | |||||
Social Media | 47 | 1 | 54 | 8 | 58 | - | 74 | - | 1 | - | 8 | |||||
Cleantech | 48 | 6 | 61 | 2 | 64 | - | 61 | 1 | 52 | - | 5 | |||||
Food & Beverage | 49 | 3 | 28 | 19 | 68 | - | 60 | 1 | 29 | 1 | 4 | |||||
Wind Energy | 50 | 3 | 55 | 4 | 67 | - | 56 | 1 | 40 | - | 2 | |||||
Pharmaceutical | 51 | 20 | 18 | 6 | 39 | - | 24 | 1 | 37 | 1 | 7 | |||||
Natural Gas | 52 | 3 | 67 | 3 | 59 | - | 58 | - | 19 | 2 | 1 | |||||
Solar Energy | 53 | 10 | 73 | 4 | 46 | 2 | 67 | - | 73 | - | 3 | |||||
Leisure & Entertainment | 54 | 2 | 42 | - | 61 | - | 52 | 2 | 71 | - | 6 | |||||
Silver Miners | 55 | 2 | 66 | - | 34 | - | 62 | - | 74 | - | 5 | |||||
Gaming | 56 | 4 | 37 | 13 | 56 | - | 53 | - | 64 | - | 7 | |||||
Healthcare Services | 57 | 2 | 14 | 3 | 53 | 1 | 26 | 2 | 30 | - | 3 | |||||
Agribusiness | 58 | 3 | 46 | 4 | 54 | 1 | 42 | 1 | 20 | 1 | 5 | |||||
Lithium | 59 | 5 | 75 | 1 | 45 | - | 71 | - | 32 | - | 3 | |||||
Airlines | 60 | 2 | 64 | 4 | 47 | 2 | 55 | 1 | 79 | - | 3 | |||||
Copper Miners | 61 | 2 | 76 | 3 | 35 | - | 66 | 1 | 44 | 5 | 1 | |||||
Transportation | 62 | 6 | 41 | 3 | 52 | 1 | 23 | 2 | 28 | 1 | 8 | |||||
Retail | 63 | 31 | 60 | 4 | 49 | 3 | 48 | 3 | 47 | 1 | 11 | |||||
Oil Equipment & Services | 64 | 1 | 65 | - | 38 | 2 | 16 | - | 41 | - | 4 | |||||
Broad Telecom | 65 | 6 | 40 | 1 | 22 | - | 10 | 1 | 55 | - | 9 | |||||
Financial Services | 66 | 8 | 4 | 1 | 28 | 1 | 72 | - | 46 | 3 | 4 | |||||
Clean Energy | 67 | - | 63 | 4 | 27 | - | 37 | - | 39 | - | 18 | |||||
Broad Energy | 68 | 2 | 53 | 1 | 33 | - | 70 | - | 25 | 1 | 7 | |||||
Broad Materials | 69 | 3 | 45 | 3 | 18 | - | 11 | - | 33 | - | 14 | |||||
Cloud Computing | 70 | 2 | 33 | 1 | 31 | - | 51 | 1 | 80 | - | 9 | |||||
Natural Resources | 71 | 3 | 59 | 1 | 19 | - | 29 | 1 | 13 | 1 | 6 | |||||
Medical Devices | 72 | 1 | 34 | 1 | 25 | - | 19 | 1 | 69 | 1 | 3 | |||||
Biotechnology | 73 | 4 | 23 | 13 | 12 | - | 36 | - | 77 | - | 22 | |||||
Broad Healthcare | 74 | 24 | 22 | 7 | 3 | - | 5 | - | 45 | 1 | 27 | |||||
Gold Miners | 75 | - | 39 | 13 | 11 | - | 43 | - | 53 | - | 14 | |||||
Metals & Mining | 76 | - | 71 | - | 32 | - | 17 | - | 31 | - | 4 | |||||
Media | 77 | - | 44 | 9 | 13 | - | 1 | - | 58 | 1 | 5 | |||||
Broad Consumer Discretionary | 78 | - | 27 | 11 | 9 | - | 3 | - | 61 | 2 | 24 | |||||
Internet | 79 | - | 62 | 1 | 17 | - | 65 | 1 | 50 | 2 | 16 | |||||
Oil & Gas Exploration & Production | 80 | - | 58 | 4 | 6 | - | 4 | - | 16 | 1 | 19 | |||||
Join ETF Database Pro and Export This Data for Free
Signup to Export This Data
|
* Ranks are updated on a weekly basis. Last updated on Sep 09, 2024
ETF issuers who have ETFs with exposure to Biotechnology are ranked on certain investment-related metrics, including estimated revenue, 3-month fund flows, 3-month return, AUM, average ETF expenses and average dividend yields. The metric calculations are based on U.S.-listed Biotechnology ETFs and every Biotechnology ETF has one issuer. If an issuer changes its ETFs, it will also be reflected in the investment metric calculations.
ETF issuers are ranked based on their estimated revenue from their ETFs with exposure to Biotechnology. Estimated revenue for an ETF issuer is calculated by aggregating the estimated revenue of the respective issuer ETFs with exposure to Biotechnology. To get the estimated issuer revenue from a single Biotechnology ETF, the AUM is multiplied by the ETF’s expense ratio. All values are in U.S. dollars.
ETF issuers are ranked based on their aggregate 3-month fund flows of their ETFs with exposure to Biotechnology. 3-month fund flows is a metric that can be used to gauge the perceived popularity amongst investors of different ETF issuers with ETFs that have exposure to Biotechnology. All values are in U.S. dollars.
ETF issuers are ranked based on their AUM-weighted average 3-month return of their ETFs with exposure to Biotechnology. In addition to price performance, the 3-month return assumes the reinvestment of all dividends during the last 3 months.
ETF issuers are ranked based on their aggregate assets under management (AUM) of their ETFs with exposure to Biotechnology. All values are in U.S. dollars.
ETF issuers are ranked based on their AUM-weighted average expense ratios of their ETFs with exposure to Biotechnology. The lower the average expense ratio of all U.S.-listed Biotechnology ETFs for a given issuer, the higher the rank.
ETF issuers are ranked based on their AUM-weighted average dividend yield of their ETFs with exposure to Biotechnology.
Issuer Issuer | Fund Flow Rank Fund Flow Rank |
+/- |
3-Month Fund Flow ($MM) 3-Month Fund Flow ($MM) | Return Rank Return Rank |
+/- |
Avg. 3-Month Return (%) Avg. 3-Month Return (%) | AUM Rank AUM Rank |
+/- |
Assets Under Management ($MM) Assets Under Management ($MM) | Expense Rank Expense Rank |
+/- |
Avg. Expense Ratio (%) Avg. Expense Ratio (%) | Dividend Rank Dividend Rank |
+/- |
Avg. Dividend Yield (%) Avg. Dividend Yield (%) | Revenue Rank Revenue Rank |
+/- |
Revenue ($MM) Revenue ($MM) | # of ETFs # of ETFs | issuer_power_ranking_sort_text issuer_power_ranking_sort_text |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AdvisorShares | - | - | - | - | - | 1 | 1 | AdvisorShares | ||||||||||||
ALPS | 2 | 1 | 1 | - | - | - | 1 | ALPS | ||||||||||||
ARK | 1 | 1 | - | - | 4 | - | 1 | ARK | ||||||||||||
ARK Investment Management | 12 | - | - | - | 1 | - | 1 | ARK Investment Management | ||||||||||||
ARK Investment Management LP | - | 1 | - | - | - | - | 1 | ARK Investment Management LP | ||||||||||||
BlackRock Financial Management | - | - | - | - | - | - | 2 | Blackrock Financial Management | ||||||||||||
BlackRock, Inc. | - | 2 | 1 | - | - | - | 2 | BlackRock, Inc. | ||||||||||||
Dawn Global Topco Ltd. | - | 1 | - | - | - | - | 2 | Dawn Global Topco Ltd. | ||||||||||||
Defiance ETFs | 1 | 1 | - | - | - | - | 1 | Defiance ETFs | ||||||||||||
Defiance ETFs, LLC | 2 | 2 | - | - | 1 | - | 1 | Defiance ETFs, LLC | ||||||||||||
Rafferty Asset Management LLC (Direxion) | 2 | - | - | - | - | - | 2 | Direxion | ||||||||||||
Exchange Traded Concepts | - | 1 | - | - | - | - | 1 | Exchange Traded Concepts | ||||||||||||
First Trust Advisors LP | 1 | 4 | - | - | - | - | 1 | First Trust | ||||||||||||
First Trust | - | 1 | - | - | - | - | 1 | First Trust | ||||||||||||
Franklin Templeton | - | - | - | - | - | 1 | 1 | Franklin Templeton | ||||||||||||
Global X Management Company LLC | 1 | 1 | - | - | - | - | 1 | Global X | ||||||||||||
Invesco Fund | 2 | - | - | - | - | - | 1 | Invesco | ||||||||||||
Invesco | - | 1 | - | - | - | - | 1 | Invesco | ||||||||||||
Barclays Global Fund Advisors | 4 | 1 | - | - | - | - | 3 | iShares | ||||||||||||
Kelly Intelligence LLC | - | 5 | 1 | - | - | - | 1 | Kelly Intelligence LLC | ||||||||||||
Mirae Asset | - | - | - | - | - | - | 1 | Mirae Asset | ||||||||||||
Mirae Asset Global Investments Co., Ltd. | - | 4 | - | - | - | - | 1 | Mirae Asset Global Investments Co., Ltd. | ||||||||||||
Principal | 1 | 3 | - | - | - | - | 1 | Principal | ||||||||||||
Principal Financial Group | 1 | 2 | - | - | - | - | 1 | Principal Financial Group | ||||||||||||
Proshare Advisors LLC | - | 1 | - | - | - | - | 2 | ProShares | ||||||||||||
ProShares | - | 1 | 1 | - | 2 | - | 2 | ProShares | ||||||||||||
Rafferty Asset Management | - | 3 | - | - | - | - | 2 | Rafferty Asset Management | ||||||||||||
SS&C | - | 6 | - | - | - | - | 1 | SS&C | ||||||||||||
State Street | - | 1 | 1 | - | - | - | 1 | State Street | ||||||||||||
State Street Bank and Trust Co./IFTC | 1 | 1 | - | - | - | - | 1 | State Street SPDR | ||||||||||||
Tema Global Ltd. | - | 4 | - | - | - | - | 1 | Tema Global Ltd. | ||||||||||||
Van Eck Associates Corp. | 3 | - | - | - | - | - | 1 | Van Eck Associates Corp. | ||||||||||||
VanEck | - | 1 | - | - | - | - | 1 | VanEck | ||||||||||||
Van Eck Associates Corporation | 2 | - | - | - | - | - | 1 | VanEck | ||||||||||||
Virtus ETF Solutions | - | 2 | - | - | - | - | 2 | Virtus | ||||||||||||
Virtus Investment Partners | - | 1 | - | - | - | - | 2 | Virtus Investment Partners | ||||||||||||
WisdomTree | - | - | - | - | - | - | 1 | WisdomTree | ||||||||||||
Join ETF Database ELITE and Export This Data
|
* Ranks are updated on a weekly basis. Last updated on Sep 09, 2024
Now that back-to-school season is in full swing, families may feel inspired to start a 529 plan...
Heading into a seasonally weak period can be cause for reviewing ETF exposures. Indeed, last...
All of Wall Street was waiting for Nvidia’s earnings report with bated breath, and the dust has...
This time of year, according to seasonal trends, is known for the September Effect — a...
The small-midcap (SMIDcap) asset class could be a compelling opportunity in the near future.
On the lookout for a strategy to pair with the growth-heavy S&P 500? The index has presented...
Even as gold prices are rising on expectations of a Fed rate cut, investors may be better...
It shouldn’t come as a surprise to hear that the robotics sector has been a highly popular...
Shares of Nvidia (NVDA) are down a staggering 17.22% for the week ending Sept. 4. That decline is...
The recent mix of economic data highlights the importance of retooling one’s portfolio ahead of...
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...